Elekta will highlight its Infinity, a linear accelerator system that is optimized to deliver volumetric modulated arc therapy (VMAT).
The system combines Elekta’s X-ray volume imaging (XVI) technology with its third generation digital control system and a new low leakage multi-leaf collimator (MLC).
The Infinity can deliver VMAT treatments in a single rotation of a gantry, or with multiple gantry arcs.
January 26, 2024 — P-Cure continues its quest to successfully usher in a new era of clinical treatment with proton ...
January 26, 2024 
October 25, 2023 — A new order for several Elekta Harmony linear accelerators (linacs) in Ukraine will complement the ...
October 25, 2023 
October 5, 2023 — A new study, led by radiation oncology physicists at Miami Cancer Institute, part of Baptist Health ...
October 05, 2023 
May 24, 2023 — RaySearch Laboratories AB announced that the oncology information system RayCare* (* subject to ...
May 24, 2023 
April 3, 2023 — P-Cure announced clearance of its Adaptive Proton Therapy Solution by the FDA for sales in the USA. P ...
April 03, 2023 
February 28, 2023 — Elekta announced that Comprehensive Motion Management (CMM) with True Tracking and automatic gating ...
February 28, 2023 
February 6, 2023 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...
February 06, 2023 
January 13, 2023 — RaySearch Laboratories AB announces that The Ohio State University Comprehensive Cancer Center - ...
January 13, 2023 
December 30, 2022 — A milestone was reached in radiation therapy last week as the first patients completed their full ...
December 30, 2022 
May 3, 2022 — Sun Nuclear Corporation, a wholly-owned subsidiary of Mirion Technologies, Inc., today announced the ...
May 03, 2022